139 related articles for article (PubMed ID: 7768774)
1. Antibacterial spectrum of fosfomycin trometamol.
Barry AL; Brown SD
J Antimicrob Chemother; 1995 Jan; 35(1):228-30. PubMed ID: 7768774
[No Abstract] [Full Text] [Related]
2. Evaluation of disk susceptibility testing of fosfomycin tromethamine.
Pfaller MA; Barry AL; Fuchs PC
Diagn Microbiol Infect Dis; 1993 Jul; 17(1):67-70. PubMed ID: 8359009
[TBL] [Abstract][Full Text] [Related]
3. Interpretive criteria and quality control parameters for determining bacterial susceptibility to fosfomycin tromethamine.
Barry AL; Pfaller MA; Fuchs PC; Tenover FC; Reller LB; Allen SD; Hardy DJ; Gerlach EH
Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):352-6. PubMed ID: 8354302
[TBL] [Abstract][Full Text] [Related]
4. Fosfomycin tromethamine susceptibility of outpatient urine isolates of Escherichia coli and Enterococcus faecalis from ten North American medical centres by three methods.
Fuchs PC; Barry AL; Brown SD
J Antimicrob Chemother; 1999 Jan; 43(1):137-40. PubMed ID: 10381112
[TBL] [Abstract][Full Text] [Related]
5. Fosfomycin tromethamine in uncomplicated urinary tract infections: an epidemiological survey.
Tempera G; Mirabile M; Mangiafico A; Caccamo M; Bonfiglio G
J Chemother; 2004 Apr; 16(2):216-7. PubMed ID: 15216960
[No Abstract] [Full Text] [Related]
6. Susceptibility testing quality control studies with fosfomycin tromethamine.
Fuchs PC; Barry AL; Brown SD
Eur J Clin Microbiol Infect Dis; 1997 Jul; 16(7):538-40. PubMed ID: 9272392
[TBL] [Abstract][Full Text] [Related]
7. [Short communication: comparison of susceptibilities of Escherichia coli urinary tract isolates against fosfomycin tromethamine and different antibiotics].
Aykut Arca E; Karabiber N
Mikrobiyol Bul; 2007 Jan; 41(1):115-9. PubMed ID: 17427560
[TBL] [Abstract][Full Text] [Related]
8. [Determination of the post-antibiotic effect of fosfomycin trometamol with bioluminescence].
Schioppacassi G; Albini E; Belluco G; Arena E
G Ital Chemioter; 1991; 38(1-3):119-21. PubMed ID: 1365562
[No Abstract] [Full Text] [Related]
9. Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections.
Patel SS; Balfour JA; Bryson HM
Drugs; 1997 Apr; 53(4):637-56. PubMed ID: 9098664
[TBL] [Abstract][Full Text] [Related]
10. Activity of fosfomycin when tested against US contemporary bacterial isolates.
Flamm RK; Rhomberg PR; Watters AA; Sweeney K; Ellis-Grosse EJ; Shortridge D
Diagn Microbiol Infect Dis; 2019 Feb; 93(2):143-146. PubMed ID: 30236530
[TBL] [Abstract][Full Text] [Related]
11. [Antibacterial activities of fosfomycin against several fresh clinical isolates--comparison of the test methods for antibacterial activity].
Hara T; Araake M; Watabe H
Jpn J Antibiot; 2002 Dec; 55(6):844-54. PubMed ID: 12621737
[TBL] [Abstract][Full Text] [Related]
12. Factors influencing the activity of the trometamol salt of fosfomycin.
Greenwood D; Jones A; Eley A
Eur J Clin Microbiol; 1986 Feb; 5(1):29-34. PubMed ID: 3084242
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of fosfomycin trometamol against pathogens from urinary tract infections: a Spanish multicenter study.
García-Rodríguez JA; Trujillano Martín I; Baquero F; Cisterna R; Gobernado M; Liñares F; Martín-Luengo F; Piédrola G
J Chemother; 1997 Dec; 9(6):394-402. PubMed ID: 9491838
[TBL] [Abstract][Full Text] [Related]
14. Antibacterial activity of fosmidomycin on chromosomic and plasmid-determined fosfomycin-resistant strains.
Mendez FJ; Alvarez AA; Mendoza MC; Hardisson C
Chemioterapia; 1985 Apr; 4(2):170-5. PubMed ID: 4006006
[TBL] [Abstract][Full Text] [Related]
15. The comparative activity of fosfomycin trometamol against organisms isolated from infected urines.
Greenwood D; Edwards R; Brown J; Ridout P
Infection; 1992; 20 Suppl 4():S302-4. PubMed ID: 1294522
[TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibility testing procedures for fosfomycin tromethamine.
Barry AL; Fuchs PC
Antimicrob Agents Chemother; 1991 Jun; 35(6):1235-8. PubMed ID: 1929270
[TBL] [Abstract][Full Text] [Related]
17. [Comparison between the in-vitro antibacterial activity of fosfomycin as determined using the M.I.C. and using the antibiogram].
Renzini G; Oliva B
G Ital Chemioter; 1977; 23(2):117-22. PubMed ID: 606610
[No Abstract] [Full Text] [Related]
18. [Antibacterial activity of fosfomycin. II. Determination of minimal bactericidal concentration in association with other antibiotics].
Grassi GG; Ferrara A; Navone A; Peona V; Sala P
G Ital Chemioter; 1977; 23(2):87-94. PubMed ID: 606614
[No Abstract] [Full Text] [Related]
19. Fosfomycin tromethamine in uncomplicated urinary tract infections: a clinical study.
Bonfiglio G; Mattina R; Lanzafame A; Cammarata E; Tempera G;
Chemotherapy; 2005 May; 51(2-3):162-6. PubMed ID: 15886477
[TBL] [Abstract][Full Text] [Related]
20. [Fosfomycin, lysine-fosfomycin, arginine-fosfomycin: antibacterial activity in vitro].
Angeretti A; Martinetto P; Valtz A
G Batteriol Virol Immunol; 1980; 73(7-12):272-80. PubMed ID: 6796449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
